
OPED BY LARRY LAMOTTE: MORNING CONSULT: PATIENT VOICE IS PARAMOUNT TO NEW FDA APPROVAL OF BIOSIMILARS
The Senate Committee on Health, Education, Labor and Pensions (HELP) held an oversight hearing yesterday on the Food and Drug Administration’s (FDA) system for approving a new class of drugs – biosimilars. The hearing was a significant step in making sure that the focus of the biosimilar approval process is ( more… )